José María Fontán, president of BIOVEGEN, analyzes in an opinion article published today by the digital Demócrata the implications of the new European regulation for NGTs. In an explanatory tone, Fontán clarifies that these improvement techniques are also based “on the process of crossing and selecting plants that we have been perfecting since the Paleolithic,” to obtain changes that could very well have arisen from nature but are now causing these desired mutations “in a much more precise way.”